The store will not work correctly when cookies are disabled.
2,6-difluoro-3-(2-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)ethoxy)benzamide
ID: ALA5084076
PubChem CID: 166627773
Max Phase: Preclinical
Molecular Formula: C15H11F2N5O5
Molecular Weight: 379.28
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCNc2ccc([N+](=O)[O-])c3nonc23)c1F
Standard InChI: InChI=1S/C15H11F2N5O5/c16-7-1-4-10(12(17)11(7)15(18)23)26-6-5-19-8-2-3-9(22(24)25)14-13(8)20-27-21-14/h1-4,19H,5-6H2,(H2,18,23)
Standard InChI Key: BFLPRLRRUSMWCC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.3472 -2.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3461 -3.2001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0567 -3.6106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7731 -3.1997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7703 -2.3699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0549 -1.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0520 -1.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7653 -0.7187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3405 -0.7230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4832 -1.9530 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6327 -1.9594 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.4882 -3.6086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2020 -3.1974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9171 -3.6064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6308 -3.1952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3459 -3.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3428 -4.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0570 -4.8422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7676 -4.4268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0530 -3.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7625 -3.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3673 -3.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0291 -2.2976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2153 -2.3903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4854 -4.8377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1984 -4.4208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4884 -5.6620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 9 2 0
6 7 1 0
5 10 1 0
1 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 21 1 0
20 16 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 20 2 0
25 26 2 0
25 27 1 0
19 25 1 0
M CHG 2 25 1 27 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.28 | Molecular Weight (Monoisotopic): 379.0728 | AlogP: 2.00 | #Rotatable Bonds: 7 |
Polar Surface Area: 146.41 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 1.52 | CX LogD: 1.52 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.36 | Np Likeness Score: -1.82 |
References
1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781] [10.1021/acs.jmedchem.0c02207] |